Quarterly report pursuant to Section 13 or 15(d)

Royalty and Commercial Payment Purchase Agreements - Bioasis (Details)

v3.23.2
Royalty and Commercial Payment Purchase Agreements - Bioasis (Details)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 20, 2023
USD ($)
Nov. 02, 2020
USD ($)
Feb. 25, 2019
USD ($)
agreement
Jun. 30, 2023
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
Agreements              
Payments of consideration under RPAs, AAAs and CPPAs         $ 14,650 $ 5,000  
Royalty purchase agreement asset impairment       $ 1,575 1,575    
Contingent consideration under RPAs, AAAs and CPPAs       1,000 1,000   $ 75
Changes in estimated fair value of contingent consideration         75    
Receipts under RPAs, AAAs and CPPAs         2,934    
Long-term royalty and commercial payment receivables       72,232 72,232   63,683
Bioasis              
Agreements              
Royalty purchase agreement asset impairment         1,575    
Bioasis | Royalty Purchase Agreement and Second Royalty Purchase Agreement              
Agreements              
Royalty purchase agreement asset impairment $ 1,600            
Reduction in long-term royalty receivables $ 1,600            
Amount of allowance for credit losses       0 0   $ 0
Long-term royalty and commercial payment receivables       0 0    
Bioasis | Royalty Purchase Agreement              
Agreements              
Percentage of option to purchase royalty right on future license agreements     1.00%        
Number of future license agreements under optional purchase right | agreement     2        
Obligation upon exercise of options per licensed product, second agreement     $ 300        
Obligation upon exercise of options per licensed product, third agreement     400        
Payments of consideration under RPAs, AAAs and CPPAs     300        
Contingent consideration under RPAs, AAAs and CPPAs     75 $ 0 $ 0    
Long-term royalty and commercial payment receivables     400        
Bioasis | Royalty Purchase Agreement | Maximum              
Agreements              
Potential future cash payments     $ 200        
Bioasis | Second Royalty Purchase Agreement              
Agreements              
Payments of consideration under RPAs, AAAs and CPPAs   $ 1,200          
Long-term royalty and commercial payment receivables   $ 1,200